Sponsored

Home and community-based care, behavioural care and speciality pharma offer fresh opportunities for healthcare investors, say The Vistria Group’s co-heads of healthcare Jon Maschmeyer, Amy Christensen and David Schuppan.

Measuring progress on gender diversity must cover everything from recruitment and retention to the pay gap and career advancement, says Liz Campbell, managing director at Portfolio Advisors.

The private equity industry must take ownership of its diversity challenge if it wants to become more inclusive and relatable, say Investec’s Nicole Goodwin and Rebecca Moss.

Competition in healthcare is intense, but PE firms can succeed if they understand the post-covid ecosystem, say KPMG’s Kristin Pothier and Glenn Mincey.

The pandemic has heightened demand for some healthcare sectors while exposing fragility in others, says 3i director Severin Matten.

Favourable conditions are spurring the country’s private equity industry into the next stage of development, say NSSK’s Jun Tsusaka and Shohei Akiyama.

Structural changes in Japanese society are driving private equity dealflow among founder-owned businesses and corporate carve-outs, say Atsushi Akaike and Daisuke Takatsuki at CVC Japan.

The fragmented Japanese waste management industry represents a compelling private equity opportunity, say J-STAR principal Masayoshi Nakajima, manager Hisato Iwamoto and managing partner Hideaki Sakurai.

Japanese LPs are looking beyond commingled funds to more customised solutions, including fund of ones and SMAs, say Neuberger Berman’s Ryo Ohira, Jonathan Shofet and Yoshi Yagisawa.

Against an increasingly bifurcated geopolitical backdrop, Japan is uniquely positioned to give investors a stable and safe access platform to Asia’s secular growth story, says Mark Chiba, group chairman and partner at The Longreach Group.